A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days
NCT00002136
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Sarcoma, Kaposi
HIV Infections
Interventions
DRUG:
Tecogalan sodium
Sponsor
Daiichi Pharmaceuticals